A 68-year-old woman with COPD (FEV₁ 35% predicted) undergoes elective hip arthroplasty under general anesthesia. Intraoperatively, she receives fentanyl 150 μg IV and vecuronium 8 mg for induction and paralysis. At the end of surgery, she is given neostigmine 5 mg IV with glycopyrrolate 1 mg IV for reversal. In the recovery room, 2 hours post-extubation, she develops progressive respiratory depression (RR 6/min, SpO₂ 85%), pinpoint pupils, and hypotension (BP 85/50). Naloxone 0.4 mg IV is given with initial improvement, but respiratory depression recurs 45 minutes later. Which pharmacokinetic property of fentanyl best explains this recurrence?

Explanation

## Fentanyl Toxicity and Naloxone Reversal Failure **Key Point:** Fentanyl has a large volume of distribution (Vd ~4 L/kg) and prolonged elimination half-life (3–12 hours), causing re-equilibration from peripheral compartments after naloxone wears off, leading to recurrent respiratory depression. ### Fentanyl Pharmacokinetics vs. Morphine | Parameter | Fentanyl | Morphine | |---|---|---| | **Volume of Distribution** | ~4 L/kg (very large) | ~3 L/kg | | **Elimination Half-life** | 3–12 hours (prolonged) | 2–3 hours | | **Protein Binding** | 80–85% | 30–35% | | **CNS Penetration** | Rapid (lipophilic) | Slower (hydrophilic) | | **Naloxone Duration** | 30–60 min | 30–60 min | | **Risk of Recurrence** | **HIGH** | Lower | ### Mechanism of Recurrent Depression ```mermaid flowchart TD A[Fentanyl 150 μg IV]:::action --> B[Rapid CNS penetration<br/>Respiratory depression]:::outcome B --> C[Naloxone 0.4 mg IV]:::action C --> D[Acute μ-receptor blockade<br/>Respiratory improvement]:::outcome D --> E{Naloxone wears off<br/>t = 30-60 min}:::decision E -->|Fentanyl redistributes<br/>from peripheral fat| F[Re-equilibration to CNS]:::outcome F --> G[Recurrent respiratory<br/>depression]:::urgent G --> H[Repeat naloxone or<br/>continuous infusion needed]:::action ``` **High-Yield:** Naloxone has a shorter duration of action (30–60 min) than fentanyl (3–12 hr half-life). After naloxone wears off, fentanyl redistributes from the large peripheral compartment back to the CNS, causing recurrence. This is a classic exam trap. **Clinical Pearl:** Fentanyl-induced respiratory depression requires either: - Repeated naloxone boluses every 30–60 min, OR - Continuous naloxone infusion (0.1–0.2 mg/kg/hr) to maintain receptor blockade until fentanyl is eliminated **Mnemonic:** **FENTANYL = Fat-Loving, Extended-duration, Needs prolonged Naloxone reversal, Accumulates in Lipid compartments, Yields recurrent toxicity** **Warning:** Do NOT assume a single naloxone dose will reverse fentanyl toxicity. Always anticipate recurrence and prepare for repeat dosing or infusion.